Skip to main content

Day: June 29, 2022

Initial Assay Results from 2022 Drill Program at Calico Silver Project Show Broad, High-Grade Silver and Expanded Gold Horizon

VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to report its first assay results from the 2022 Drill Program at the Calico Silver Project’s Waterloo Property (“Calico” or the “Project”) located in San Bernardino County, California. Assay results continue to show near-surface, broad, high-grade silver mineralization. Results have also verified and expanded the gold mineralized horizon at the Barstow-Pickhandle contact, as discussed in the Company’s news release dated January 11, 2022. Results below are reported for 10 reverse circulation (“RC”) drill holes (see Table 1) which were drilled between early April and early May 2022. The 2022 Drill Program at Calico is proceeding as planned. A total of 37 holes (4,139.50...

Continue reading

Boralex ranks among Corporate Knights’ 2022 Best 50 Corporate Citizens in Canada

MONTREAL, June 29, 2022 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) is pleased to announce that it has been named one of Canada’s “Best 50 Corporate Citizens” by Corporate Knights, a sustainable economy magazine. Since 2002, this ranking has recognized companies for their leadership in sustainability. To determine the ranking for 2022, Corporate Knights analysed 332 large Canadian organizations against Canadian and global industry peers on a suite of 24 quantitative key performance indicators.1 Boralex excelled on three indicators:CEO–Average Worker Pay Ratio Board and Executive Gender Diversity Clean Revenue (earned from clean energy generation)The Company’s performance earned 23rd place in the ranking. “At Boralex, corporate social responsibility (CSR) has long been at the heart of our business...

Continue reading

PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patch

Successfully delivered ketamine and KETABET™ (ketamine and betaine) via microneedle patch, unlocking the potential for desired dosage forms and pharmacokinetic profiles Pursuing Phase 2 clinical studies in treatment-resistant depression and pain indications in Q4-2022 TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, is pleased to announce that it has successfully completed its research study evaluating the Company’s patented hydrogel-forming microneedle patch, PHARMAPATCH™, to deliver ketamine and KETABET™ (ketamine and betaine anhydrous), which aims to prevent the potential side effects of repeated ketamine treatment for depression and other indications, including suicidal ideation, substance abuse, post-traumatic...

Continue reading

Inventus Mining: Critical Mineral Flow-Through Private Placement and Unit Offering

Not for Distribution to United States Wire Services or Dissemination in the United States TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSX VENTURE: IVS) (“Inventus” or the “Company”) is pleased to announce a non-brokered private placement for up to 3,500,000 critical mineral(1) flow-through units of the Company (each, a “CMFT Unit”) at a price of $0.15 per CMFT Unit and additionally up to 4,500,000 units of the Company (each, a “Unit”) at a price of $0.105 per Unit, for total gross proceed of up to $997,500 (the “Offering”). Each CMFT Unit will consist of one (1) common share of the Company to be issued as a “flow-through share” within the meaning of the Income Tax Act (Canada) (each, a “CMFT Share”) and one-half (0.5) of a share purchase warrant. Each whole warrant (a “CMFT Warrant”) shall entitle the holder...

Continue reading

CE Brands Announces Stock Option Grants

CALGARY, Alberta, June 29, 2022 (GLOBE NEWSWIRE) — CE Brands Inc. (TSXV: CEBI; CEBI.WT) (“CE Brands”, “we”, “our”, or the “Company”), a data-driven consumer-electronics company, is pleased to announce that the Company’s board of directors has approved the grant of stock options (the “Options”) exercisable for a total of 310,000 common shares, including 200,000 Options granted to an officer of the Company. All Options were granted pursuant to the Company’s amended and restated 2022 stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange. The Options were granted at an exercise price of $0.21, being the closing price on June 28, 2022. The Options shall vest on June 29, 2023, being the first anniversary following the date of the grant, and shall expire on June...

Continue reading

Unigold provides update on activities; releases first ESG report

TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Unigold Inc. (“Unigold” or the “Company”) (TSX-V:UGD; OTCQX: UGDIF; FSE:UGB1) is pleased to provide an update on permitting, engineering and environmental activities surrounding the Candelones Oxide Project. Activities remain on schedule and the Company expects to be able to deliver a NI43-101 compliant feasibility study (“FS”), an Environmental and Social Impact Assessment (“ESIA”) and an approved Exploitation Concession licence during the third quarter of this year. In late February 2022, the Company submitted an application to convert a portion of the Neita Exploration Concession into an Exploitation Concession. The application was accepted as complete by the Dirección General de Minería and published in the national press as required by Dominican Mining Law. No material comments were...

Continue reading

Nuwellis Announces First Patient Enrolled in its Pivotal Trial REVERSE-HF

REVERSE-HF will evaluate ultrafiltration therapy in comparison to IV diuretics to treat heart failure patients with fluid overload MINNEAPOLIS, June 29, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) today announced the first patient has been enrolled in the company’s pivotal REVERSE-HF (Ultrafiltration Versus IV Diuretics in Worsening Heart Failure) clinical study. REVERSE-HF will evaluate the clinical outcomes and economic value of its Aquadex® ultrafiltration therapy in comparison to intravenous (IV) diuretics for the treatment of fluid overload in patients with worsening heart failure. The first patient was enrolled by Dr. Sirish Vullaganti, M.D. at Northwell Health in New York City. “Heart failure is among the leading causes of hospitalizations due to the accumulation of fluid requiring decongestion in the hospital...

Continue reading

BioAdaptives, Inc. Brings Top Revolutionary Formulas Together in Wellness Introductory Offer

Responding to Consumers, Management Offers Cost-Effective Combination With Enhanced Synergistic Benefits LAS VEGAS, NV , June 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT), responding to heightened interest and demand largely generated by the emergence of new health issues, has developed a sample wellness combination offer, consisting of three effective formulas, PluriPain®, PrimiLungs™, and PrimiSleep™ (soon to be launched).  Management believes, based on studies and consumer feedback, that these three products, when consumed together, can help to manage an array of chronic symptoms like “brain fog”, pain, fatigue, depressed mood, and sleep disturbance. These symptoms seem to be interrelated, are poorly understood, and may be associated with a variety of possible causes including a stressful...

Continue reading

Healthcare Trust of America, Inc. Announces Results of Early Participation in Exchange Offers and Consent Solicitations

Holders of greater than 97% of HR Notes agree to exchange during early consent period SCOTTSDALE, Ariz., June 29, 2022 (GLOBE NEWSWIRE) — Healthcare Trust of America, Inc. (“HTA”, NYSE: HTA) announced today that, as of 5:00 p.m., New York City time, on June 28, 2022 (the “Early Consent Date”), the aggregate principal amounts of each series of notes listed in the table below (collectively, the “HR Notes”) previously issued by Healthcare Realty Trust Incorporated (“HR”), had been validly tendered and not validly withdrawn in connection with HTA’s previously announced offers to exchange all validly tendered and accepted HR Notes of each such series for notes to be issued by Healthcare Trust of America Holdings, LP (“HTA OP” and together with HTA, the “Company”), and the related solicitation of consents from holders of the HR Notes...

Continue reading

KULR Receives Follow-On Phase Change Material Heat Sink Order from Lockheed Martin

SAN DIEGO, June 29, 2022 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion battery safety and thermal management technologies, announced today it received a follow-on order for its space-developed phase change material (“PCM”) heat sink technology from leading aerospace and defense company Lockheed Martin Corporation (NYSE: LMT). Phase change material heat sink technology reduces system temperature excursions and extends both the life of key components within the thermal storage process. The solution is most useful for compact and high-performance devices that require bursts of computational power in short time intervals. KULR’s PCM heat sink technology is compact, reliable, and lightweight and has been utilized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.